Detailansicht

Wissensnetz

Person

Constantinos Zamboglou

Arzt

Name	Constantinos Zamboglou
Ort	Essen (Geburtsort) Freiburg im Breisgau (Wirkungsort) Deutschland
Akademischer Grad bzw. Titel	Dr. med.
Beruf	Arzt (charakteristischer Beruf)
Variante	C. Zamboglou
Beziehung	Universitätsklinikum Freiburg. Klinik für Strahlenheilkunde
Weitere Angaben	Diss. 2013, Universität Freiburg, Medizinische Fakultät
Datensatztyp	Person
GND-Nummer	1103258354
Datensatz-ID	1103258354
Beteiligt an alle anzeigen The impact of multicentric datasets for the automated tumor delineation in primary prostate cancer using convolutional neural networks on 18F-PSMA-1007 PET Role of enzalutamide in primary and recurrent non-metastatic hormone sensitive prostate cancer: a systematic review of prospective clinical trials A convolutional attention model for predicting response to chemo-immunotherapy from ultrasound elastography in mouse tumor models A multicenter evaluation of different chemotherapy regimens in older adults with head and neck squamous cell carcinoma undergoing definitive chemoradiation A student trained convolutional neural network competing with a commercial AI software and experts in organ at risk segmentation Comparison of data fusion strategies for automated prostate lesion detection using mpMRI correlated with whole mount histology European association of urology risk stratification predicts outcome in patients receiving PSMA-PET-planned salvage radiotherapy for biochemical recurrence following radical prostatectomy Exploring the role of combined external beam radiotherapy and targeted radioligand therapy with [177Lu]Lu-PSMA-617 for prostate cancer - from bench to bedside Implementation of PET/CT in radiation oncology - a patterns-of-care analysis of the German Society of Nuclear Medicine and the German Society of Radiation Oncology Predictors of radiation-induced late rectal toxicity in prostate cancer treatment: a volumetric and dosimetric analysis Prostate cancer and elective nodal radiation therapy for cN0 and pN0—a never ending story? : : Recommendations from the prostate cancer expert panel of the German Society of Radiation Oncology (DEGRO) Radiomics-based prediction of local control in patients with brain metastases following postoperative stereotactic radiotherapy Role of enzalutamide in primary and recurrent non-metastatic hormone sensitive prostate cancer: a systematic review of prospective clinical trials The impact of multicentric datasets for the automated tumor delineation in primary prostate cancer using convolutional neural networks on 18F-PSMA-1007 PET The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy Using multiparametric magnetic resonance imaging and prostate specific membrane antigen positron emission tomography to detect and delineate the gross tumour volume of intraprostatic lesions – a systematic review and meta-analysis Whole pelvis vs. hemi pelvis elective nodal radiotherapy in patients with PSMA-positive nodal recurrence after radical prostatectomy - a retrospective multi-institutional propensity score analysis The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml A clinical evaluation of the performance of five commercial artificial intelligence contouring systems for radiotherapy Deep inspiration breath-hold radiation therapy in left-sided breast cancer patients: a single-institution retrospective dosimetric analysis of organs at risk doses Deep Learning based automated delineation of the intraprostatic gross tumour volume in PSMA-PET for patients with primary prostate cancer Development and validation of a multi-institutional nomogram of outcomes for PSMA-PET–based salvage radiotherapy for recurrent prostate cancer Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy Evaluation of concomitant systemic treatment in older adults with head and neck squamous cell carcinoma undergoing definitive radiotherapy Genomic classifiers in personalized prostate cancer radiotherapy approaches – a systematic review and future perspectives based on international consensus Identifying core MRI sequences for reliable automatic brain metastasis segmentation Investigation and benchmarking of U-Nets on prostate segmentation tasks PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml The effect of statins on the incidence and prognosis of bladder cancer: a systematic review and meta-analysis Towards improving the efficacy of PSMA-targeting radionuclide therapy for late-stage prostate cancer - combination strategies Prognostic value of tumor-infiltrating immune cells and immune checkpoints in elderly head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiotherapy Deep inspiration breath-hold radiation therapy in left-sided breast cancer patients: a single-institution retrospective dosimetric analysis of organs at risk doses Palliative radiotherapy of bone metastases in octogenarians: How do the oldest olds respond? Results from a tertiary cancer center with 288 treated patients The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy—a multicenter retrospective analysis Explainable AI for CNN-based prostate tumor segmentation in multi-parametric MRI correlated to whole mount histopathology Feasibility, pitfalls and results of a structured concept-development phase for a randomized controlled phase III trial on radiotherapy in primary prostate cancer patients Editorial: Advances in radiotherapy for prostate cancer Editorial: Exploring the potential of PSMA-PET imaging on personalized prostate cancer treatment Ex vivo [gamma]H2AX assay for tumor radiosensitivity in primary prostate cancer patients and correlation with clinical parameters Explainable AI for CNN-based prostate tumor segmentation in multi-parametric MRI correlated to whole mount histopathology Feasibility, pitfalls and results of a structured concept-development phase for a randomized controlled phase III trial on radiotherapy in primary prostate cancer patients Intraindividual comparison between [18F] PSMA-1007 PET/CT and multiparametric MRI for radiotherapy planning in primary prostate cancer patients Palliative radiotherapy of bone metastases in octogenarians: How do the oldest olds respond? Results from a tertiary cancer center with 288 treated patients Patterns-of-Care analysis for radiotherapy of elderly head-and-neck cancer patients: a trinational survey in Germany, Austria and Switzerland Prognostic value of tumor-infiltrating immune cells and immune checkpoints in elderly head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiotherapy PSMA-PET- and MRI-based focal dose escalated radiotherapy of primary prostate cancer: planned safety analysis of a non-randomized 2-armed phase II trial (ARO2020-01) Risk factors for biochemical recurrence after PSMA-PET-guided definitive radiotherapy in patients with de novo lymph node-positive prostate cancer The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy - a multicenter retrospective analysis Innovative radiation oncology Together – Precise, Personalized, Human : Vision 2030 for radiotherapy & radiation oncology in Germany Moderately hypofractionated radiotherapy as definitive treatment for localized prostate cancer: Pattern of practice in German-speaking countries : A survey of the Prostate Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO) and the Working Party on Radiation Oncology of the German Cancer Society (DKG-ARO) The value of primary and adjuvant radiotherapy for cutaneous squamous cell carcinomas of the head-and-neck region in the elderly Radiotherapy in nodal oligorecurrent prostate cancer 18F-FMISO-PET hypoxia monitoring for head-and-neck cancer patients: radiomics analyses predict the outcome of chemo-radiotherapy A multi-institutional analysis of prostate cancer patients with or without 68Ga-PSMA PET/CT prior to salvage radiotherapy of the prostatic fossa A multi-institutional analysis of prostate cancer patients with or without 68Ga-PSMA PET/CT prior to salvage radiotherapy of the prostatic fossa Changes in blood biomarkers of angiogenesis and immune modulation after radiation therapy and their association with outcomes in thoracic malignancies Combining 68Ga-PSMA-PET/CT-directed and elective radiation therapy improves outcome in oligorecurrent prostate cancer: a retrospective multicenter study FAK inhibition radiosensitizes pancreatic ductal adenocarcinoma cells in vitro

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Constantinos Zamboglou

The impact of multicentric datasets for the automated tumor delineation in primary prostate cancer using convolutional neural networks on 18F-PSMA-1007 PET

Role of enzalutamide in primary and recurrent non-metastatic hormone sensitive prostate cancer: a systematic review of prospective clinical trials

A convolutional attention model for predicting response to chemo-immunotherapy from ultrasound elastography in mouse tumor models

A multicenter evaluation of different chemotherapy regimens in older adults with head and neck squamous cell carcinoma undergoing definitive chemoradiation

A student trained convolutional neural network competing with a commercial AI software and experts in organ at risk segmentation

Comparison of data fusion strategies for automated prostate lesion detection using mpMRI correlated with whole mount histology

European association of urology risk stratification predicts outcome in patients receiving PSMA-PET-planned salvage radiotherapy for biochemical recurrence following radical prostatectomy

Exploring the role of combined external beam radiotherapy and targeted radioligand therapy with [177Lu]Lu-PSMA-617 for prostate cancer - from bench to bedside

Implementation of PET/CT in radiation oncology - a patterns-of-care analysis of the German Society of Nuclear Medicine and the German Society of Radiation Oncology

Predictors of radiation-induced late rectal toxicity in prostate cancer treatment: a volumetric and dosimetric analysis

Prostate cancer and elective nodal radiation therapy for cN0 and pN0—a never ending story? : : Recommendations from the prostate cancer expert panel of the German Society of Radiation Oncology (DEGRO)

Radiomics-based prediction of local control in patients with brain metastases following postoperative stereotactic radiotherapy

Role of enzalutamide in primary and recurrent non-metastatic hormone sensitive prostate cancer: a systematic review of prospective clinical trials

The impact of multicentric datasets for the automated tumor delineation in primary prostate cancer using convolutional neural networks on 18F-PSMA-1007 PET

The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy

Using multiparametric magnetic resonance imaging and prostate specific membrane antigen positron emission tomography to detect and delineate the gross tumour volume of intraprostatic lesions – a systematic review and meta-analysis

Whole pelvis vs. hemi pelvis elective nodal radiotherapy in patients with PSMA-positive nodal recurrence after radical prostatectomy - a retrospective multi-institutional propensity score analysis

The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy

Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy

PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml

A clinical evaluation of the performance of five commercial artificial intelligence contouring systems for radiotherapy

Deep inspiration breath-hold radiation therapy in left-sided breast cancer patients: a single-institution retrospective dosimetric analysis of organs at risk doses

Deep Learning based automated delineation of the intraprostatic gross tumour volume in PSMA-PET for patients with primary prostate cancer

Development and validation of a multi-institutional nomogram of outcomes for PSMA-PET–based salvage radiotherapy for recurrent prostate cancer

Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy

Evaluation of concomitant systemic treatment in older adults with head and neck squamous cell carcinoma undergoing definitive radiotherapy

Genomic classifiers in personalized prostate cancer radiotherapy approaches – a systematic review and future perspectives based on international consensus

Identifying core MRI sequences for reliable automatic brain metastasis segmentation

Investigation and benchmarking of U-Nets on prostate segmentation tasks

PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml

The effect of statins on the incidence and prognosis of bladder cancer: a systematic review and meta-analysis

Towards improving the efficacy of PSMA-targeting radionuclide therapy for late-stage prostate cancer - combination strategies

Prognostic value of tumor-infiltrating immune cells and immune checkpoints in elderly head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiotherapy

Deep inspiration breath-hold radiation therapy in left-sided breast cancer patients: a single-institution retrospective dosimetric analysis of organs at risk doses

Palliative radiotherapy of bone metastases in octogenarians: How do the oldest olds respond? Results from a tertiary cancer center with 288 treated patients

The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy—a multicenter retrospective analysis

Explainable AI for CNN-based prostate tumor segmentation in multi-parametric MRI correlated to whole mount histopathology

Feasibility, pitfalls and results of a structured concept-development phase for a randomized controlled phase III trial on radiotherapy in primary prostate cancer patients

Editorial: Advances in radiotherapy for prostate cancer

Editorial: Exploring the potential of PSMA-PET imaging on personalized prostate cancer treatment

Ex vivo [gamma]H2AX assay for tumor radiosensitivity in primary prostate cancer patients and correlation with clinical parameters

Explainable AI for CNN-based prostate tumor segmentation in multi-parametric MRI correlated to whole mount histopathology

Feasibility, pitfalls and results of a structured concept-development phase for a randomized controlled phase III trial on radiotherapy in primary prostate cancer patients

Intraindividual comparison between [18F] PSMA-1007 PET/CT and multiparametric MRI for radiotherapy planning in primary prostate cancer patients

Palliative radiotherapy of bone metastases in octogenarians: How do the oldest olds respond? Results from a tertiary cancer center with 288 treated patients

Patterns-of-Care analysis for radiotherapy of elderly head-and-neck cancer patients: a trinational survey in Germany, Austria and Switzerland

Prognostic value of tumor-infiltrating immune cells and immune checkpoints in elderly head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiotherapy

PSMA-PET- and MRI-based focal dose escalated radiotherapy of primary prostate cancer: planned safety analysis of a non-randomized 2-armed phase II trial (ARO2020-01)

Risk factors for biochemical recurrence after PSMA-PET-guided definitive radiotherapy in patients with de novo lymph node-positive prostate cancer

The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy - a multicenter retrospective analysis

Innovative radiation oncology Together – Precise, Personalized, Human : Vision 2030 for radiotherapy & radiation oncology in Germany

The value of primary and adjuvant radiotherapy for cutaneous squamous cell carcinomas of the head-and-neck region in the elderly

Radiotherapy in nodal oligorecurrent prostate cancer

18F-FMISO-PET hypoxia monitoring for head-and-neck cancer patients: radiomics analyses predict the outcome of chemo-radiotherapy

A multi-institutional analysis of prostate cancer patients with or without 68Ga-PSMA PET/CT prior to salvage radiotherapy of the prostatic fossa

A multi-institutional analysis of prostate cancer patients with or without 68Ga-PSMA PET/CT prior to salvage radiotherapy of the prostatic fossa

Changes in blood biomarkers of angiogenesis and immune modulation after radiation therapy and their association with outcomes in thoracic malignancies

Combining 68Ga-PSMA-PET/CT-directed and elective radiation therapy improves outcome in oligorecurrent prostate cancer: a retrospective multicenter study

FAK inhibition radiosensitizes pancreatic ductal adenocarcinoma cells in vitro